Netherlands

Last Updated 1 March 2021.

3 Vaccines Approved for Use in Netherlands

• Moderna
  mRNA-1273

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 40 countries

  6 trials in 1 country

  RNA

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 67 countries

  11 trials in 9 countries

  RNA

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 58 countries

  22 trials in 13 countries

  Non Replicating Viral Vector

2 Vaccines in Clinical Trials in Netherlands

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 3 other countries

  6 trials in 17 countries

  Non Replicating Viral Vector

• University Medical Center Groningen
  AKS-452

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 2 trials.

  2 trials in 1 country

  Protein Subunit